wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38848537-19DB18B5-5515-43A9-B8F5-D87D061D8ECA
Q38848537-19DB18B5-5515-43A9-B8F5-D87D061D8ECA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38848537-19DB18B5-5515-43A9-B8F5-D87D061D8ECA
Advanced Hepatocellular Cancer: the Current State of Future Research.
P2860
Q38848537-19DB18B5-5515-43A9-B8F5-D87D061D8ECA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38848537-19DB18B5-5515-43A9-B8F5-D87D061D8ECA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f8d0e8a0a9eeaeaaec6613c20c922fb9206e3909
P2860
Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma.